NCT02956915View on ClinicalTrials.gov

Evaluation of Length of Stay After TF-TAVI

CompletedOBSERVATIONAL
Enrollment

300

Participants

Timeline

Start Date

May 22, 2017

Primary Completion Date

February 23, 2018

Study Completion Date

February 23, 2018

Conditions
Severe Symptomatic Aortic Stenosis
Interventions
PROCEDURE

Transfemoral Transcatheter aortic valve implantation

Transcatheter aortic valve implantation (TAVI): The SAPIEN-3 prosthese are implanted without open heart surgery. The valve delivery system is inserted in the body via the femoral artery.

Trial Locations (5)

Unknown

Brest University Hospital, Brest

Jacques Cartier Private Hospital, Massy

AP-HP Bichat - Claude Bernard Hospital, Paris

Rennes University Hospital, Rennes

Rouen University Hospital, Rouen

All Listed Sponsors
lead

University Hospital, Rouen

OTHER

NCT02956915 - Evaluation of Length of Stay After TF-TAVI | Biotech Hunter | Biotech Hunter